Business Information
The group's principal activities are to research, develop and commercialize proprietary products focused on drug delivery and vaccine development. The group sells, markets and distributes a line of women's health prescription pharmaceuticals throughout the United States. It also conducts research and development on preventative and therapeutic vaccines and proteins for a variety of infectious diseases, including smallpox, HIV, sars, papilloma, influenza and e-selection tolerogen for the prevention of stroke. The group markets its products through its specialty sales force calling on obstetricians and gynecologists. The products of the group include nestabs(R) , novanatal(R) and novastart(R), a line of prescription prenatal vitamins, gynodiol(R) (estradiol tablets, usp), an oral form of estrogen therapy, avc(tm) cream (sulphanilamide vaginal cream) for vaginal infections and analpram hc(R), a prescription corticosteroid and antipruritic product for hemorrhoids.
|
|
Name |
Title
|
Email
|
| John Lambert | Chmn. | Available | | Len Stigliano | CFO, VP, Treasurer | Available | | Penny Heaton | Chief Medical Officer, VP | Available | | Gale Smith | VP - Vaccine Development | Available | | James Robinson | VP - Technical, Quality Operations | Available
|
|
|
Year |
Sales |
Net Income |
| 2006 | 4,683 | (23,068) | | 2005 | 7,388 | (11,174) | | 2004 | 8,260 | (25,920)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
